We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.06B
AUM Growth
+$442M
Cap. Flow
+$399M
Cap. Flow %
19.35%
Top 10 Hldgs %
32.73%
Holding
584
New
175
Increased
109
Reduced
81
Closed
182

Sector Composition

Rank Sector Weight
1 Real Estate 25.91%
2 Consumer Discretionary 8.43%
3 Financials 6.54%
4 Industrials 6%
5 Utilities 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELLI
326
DELISTED
Ellie Mae Inc
ELLI
$502K 0.02%
+6,000
New +$554K
LUMN icon
327
Lumen
LUMN
$6.53B
$497K 0.02%
+20,881
New +$530K
VIV icon
328
Telefônica Brasil
VIV
$22.4B
$495K 0.02%
+37,000
New +$496K
SWBI icon
329
Smith & Wesson
SWBI
$655M
$491K 0.02%
+30,315
New +$560K
IIP
330
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$485K 0.02%
+315,000
New +$485K
IONS icon
331
Ionis Pharmaceuticals
IONS
$9.35B
$478K 0.02%
10,000
TUES
332
PUT
DELISTED
Tuesday Morning Corp
TUES
$469K 0.02%
+86,900
New +$467K
FE icon
333
FirstEnergy
FE
$28.9B
$463K 0.02%
+14,950
New +$479K
DB icon
334
PUT
Deutsche Bank
DB
$66.3B
$453K 0.02%
+28,000
New +$394K
LLY icon
335
Eli Lilly
LLY
$1.07T
$451K 0.02%
6,138
-4,973
-45% -$370K
DXCM icon
336
CALL
DexCom
DXCM
$27.6B
$448K 0.02%
+30,000
New +$531K
ADAP
337
DELISTED
Adaptimmune Therapeutics
ADAP
$446K 0.02%
110,000
+46,000
+72% +$221K
TCOM icon
338
Trip.com Group
TCOM
$27.5B
$440K 0.02%
11,000
-58,295
-84% -$2.55M
WLH
339
DELISTED
WILLIAM LYON HOMES
WLH
$436K 0.02%
+22,899
New +$434K
ZLTQ
340
PUT
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$435K 0.02%
+10,000
New +$403K
PETX
341
DELISTED
Aratana Therapeutics, Inc.
PETX
$431K 0.02%
60,000
INFN
342
DELISTED
Infinera Corporation Common Stock
INFN
$425K 0.02%
+50,000
New +$428K
IMPV
343
DELISTED
Imperva, Inc.
IMPV
$422K 0.02%
11,000
-99,080
-90% -$4.02M
RPM icon
344
RPM International
RPM
$13.7B
$408K 0.02%
+7,572
New +$388K
PACB icon
345
Pacific Biosciences
PACB
$422M
$407K 0.02%
107,000
IMMU
346
DELISTED
Immunomedics Inc
IMMU
$404K 0.02%
110,000
+33,000
+43% +$97.6K
XLRN
347
DELISTED
Acceleron Pharma
XLRN
$383K 0.02%
15,000
-578
-4% -$18.3K
CRIS icon
348
Curis
CRIS
$9.53M
$382K 0.02%
62
STAA icon
349
STAAR Surgical
STAA
$1.16B
$380K 0.02%
35,000
-4,000
-10% -$40.7K
TKR icon
350
Timken Company
TKR
$9.82B
$377K 0.02%
+9,499
New +$353K

Similar funds

Weiss Multi-Strategy Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, Weiss Multi-Strategy Advisers held 584 positions worth $2.06B, up 27% from $1.62B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Weiss Multi-Strategy Advisers deployed $399M of net new capital in Q4 2016, opening 175 new positions and adding to 109 existing holdings. Its largest new stake was Boston Properties: 455,075 shares worth $57.2M.

By sector, the portfolio is most concentrated in Real Estate at 26% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Foot Locker, an estimated $15.1M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q4 2016 buy was Boston Properties: 455,075 shares worth $57.2M.
  • Weiss Multi-Strategy Advisers added most to State Street SPDR S&P 500 ETF Trust in Q4 2016, an estimated $307M increase.
  • Weiss Multi-Strategy Advisers's biggest Q4 2016 reduction was Foot Locker, cutting an estimated $15.1M.
  • Weiss Multi-Strategy Advisers fully exited Liberty Property Trust in Q4 2016, selling an estimated $17.6M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 33% of its $2.06B portfolio in Q4 2016.
  • Weiss Multi-Strategy Advisers opened 175 new positions and closed 182 in Q4 2016.
  • Weiss Multi-Strategy Advisers's portfolio value rose 27% quarter-over-quarter to $2.06B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.